[Transmembrane sodium transport systems in various forms of hyperlipoproteinemia]. 1996

A Saitta, and M N Saitta, and A Messina, and M Bonaiuto, and M Castaldo, and M Cinquegrani, and E Imbalzano, and C Mangano, and G Giordano, and G Vollero, and A Sardo, and S Totaro
Cattedra di Terapia Medica, Università degli Studi, Messina.

The possible interrelationships between the erythrocytic transport systems of Na+ (Na+/K+ pump, Na+/K+ cotransport, Na+/Li+ countertransport, Na+ passive permeability) and the plasmatic lipids (cholesterol, triglycerides, HDL, LDL, apoprotein A1, apoprotein B) were studied in 42 normotensive subjects with different forms of hyperlipoproteinaemia and with a negative familiarity for arterial hypertension. In subjects with hypercholesterolaemia (hyperlipoproteinaemia II A and II B) an elevated activity of the Na+/K+ pump was noticed, while in subjects with hypertriglyceridaemia (type IV) an increase in Na+ passive permeability and Na+/Li+ countertransport with a lower level of intraerythrocytic Na+ was shown. A negative correlation was observed between the total efflux of Na+ and Na+/K+ pump and the levels of cholesterol (r = -0.43, p < 0.04 and r = -0.41, p < 0.05) and the apoprotein B/A ratio (r = 0.42, p < 0.05 and r = -0.50, p < 0.01). A negative correlation was also noticed between the Na+/K+ pump and the levels of apoprotein B (r = -0.41, p < 0.05). The Na+/K+ cotransport appeared inversely correlated with the levels of HDL cholesterol (r = -0.42, p < 0.05), while the Na+ passive permeability was negatively correlated with the levels of LDL (r = -0.43, p < 0.04) and positively correlated with the plasmatic triglycerides (r = +0.54, p < 0.01). Such data show that the plasmatic lipids can influence the systems of transmembrane ionic transport of Na+ and play an important role also this way, in cardiovascular pathology.

UI MeSH Term Description Entries
D006951 Hyperlipoproteinemias Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. Hyperlipoproteinemia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004910 Erythrocyte Membrane The semi-permeable outer structure of a red blood cell. It is known as a red cell 'ghost' after HEMOLYSIS. Erythrocyte Ghost,Red Cell Cytoskeleton,Red Cell Ghost,Erythrocyte Cytoskeleton,Cytoskeleton, Erythrocyte,Cytoskeleton, Red Cell,Erythrocyte Cytoskeletons,Erythrocyte Ghosts,Erythrocyte Membranes,Ghost, Erythrocyte,Ghost, Red Cell,Membrane, Erythrocyte,Red Cell Cytoskeletons,Red Cell Ghosts
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000254 Sodium-Potassium-Exchanging ATPase An enzyme that catalyzes the active transport system of sodium and potassium ions across the cell wall. Sodium and potassium ions are closely coupled with membrane ATPase which undergoes phosphorylation and dephosphorylation, thereby providing energy for transport of these ions against concentration gradients. ATPase, Sodium, Potassium,Adenosinetriphosphatase, Sodium, Potassium,Na(+)-K(+)-Exchanging ATPase,Na(+)-K(+)-Transporting ATPase,Potassium Pump,Sodium Pump,Sodium, Potassium ATPase,Sodium, Potassium Adenosinetriphosphatase,Sodium-Potassium Pump,Adenosine Triphosphatase, Sodium, Potassium,Na(+) K(+)-Transporting ATPase,Sodium, Potassium Adenosine Triphosphatase,ATPase Sodium, Potassium,ATPase, Sodium-Potassium-Exchanging,Adenosinetriphosphatase Sodium, Potassium,Pump, Potassium,Pump, Sodium,Pump, Sodium-Potassium,Sodium Potassium Exchanging ATPase,Sodium Potassium Pump
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015222 Sodium Channels Ion channels that specifically allow the passage of SODIUM ions. A variety of specific sodium channel subtypes are involved in serving specialized functions such as neuronal signaling, CARDIAC MUSCLE contraction, and KIDNEY function. Ion Channels, Sodium,Ion Channel, Sodium,Sodium Channel,Sodium Ion Channels,Channel, Sodium,Channel, Sodium Ion,Channels, Sodium,Channels, Sodium Ion,Sodium Ion Channel

Related Publications

A Saitta, and M N Saitta, and A Messina, and M Bonaiuto, and M Castaldo, and M Cinquegrani, and E Imbalzano, and C Mangano, and G Giordano, and G Vollero, and A Sardo, and S Totaro
January 1972, Biophysik,
A Saitta, and M N Saitta, and A Messina, and M Bonaiuto, and M Castaldo, and M Cinquegrani, and E Imbalzano, and C Mangano, and G Giordano, and G Vollero, and A Sardo, and S Totaro
October 1973, Terapevticheskii arkhiv,
A Saitta, and M N Saitta, and A Messina, and M Bonaiuto, and M Castaldo, and M Cinquegrani, and E Imbalzano, and C Mangano, and G Giordano, and G Vollero, and A Sardo, and S Totaro
January 1990, VASA. Supplementum,
A Saitta, and M N Saitta, and A Messina, and M Bonaiuto, and M Castaldo, and M Cinquegrani, and E Imbalzano, and C Mangano, and G Giordano, and G Vollero, and A Sardo, and S Totaro
January 1999, International review of cytology,
A Saitta, and M N Saitta, and A Messina, and M Bonaiuto, and M Castaldo, and M Cinquegrani, and E Imbalzano, and C Mangano, and G Giordano, and G Vollero, and A Sardo, and S Totaro
January 1968, Dermatologica,
A Saitta, and M N Saitta, and A Messina, and M Bonaiuto, and M Castaldo, and M Cinquegrani, and E Imbalzano, and C Mangano, and G Giordano, and G Vollero, and A Sardo, and S Totaro
January 1988, The American journal of medicine,
A Saitta, and M N Saitta, and A Messina, and M Bonaiuto, and M Castaldo, and M Cinquegrani, and E Imbalzano, and C Mangano, and G Giordano, and G Vollero, and A Sardo, and S Totaro
August 2011, Chemical communications (Cambridge, England),
A Saitta, and M N Saitta, and A Messina, and M Bonaiuto, and M Castaldo, and M Cinquegrani, and E Imbalzano, and C Mangano, and G Giordano, and G Vollero, and A Sardo, and S Totaro
February 1990, Journal of cardiovascular pharmacology,
A Saitta, and M N Saitta, and A Messina, and M Bonaiuto, and M Castaldo, and M Cinquegrani, and E Imbalzano, and C Mangano, and G Giordano, and G Vollero, and A Sardo, and S Totaro
January 1976, Acta poloniae pharmaceutica,
A Saitta, and M N Saitta, and A Messina, and M Bonaiuto, and M Castaldo, and M Cinquegrani, and E Imbalzano, and C Mangano, and G Giordano, and G Vollero, and A Sardo, and S Totaro
September 1986, Wiener medizinische Wochenschrift (1946),
Copied contents to your clipboard!